In this Talks with Teads episode, Kevin Reilly—President of Alexandria Hyundai and a national voice for Hyundai and Genesis dealers—joins Henner Blömer, Teads’ Global VP of Automotive. Reilly shares how Hyundai Hope On Wheels evolved from a local fundraising effort into a national—and now global—movement to fight pediatric cancer, powered by purpose and partnership.
Key Insights
A Dealer’s Vision, A National Mission
Hope On Wheels began when a fellow dealer in New England started raising funds for pediatric cancer research. Kevin Reilly saw the potential for greater impact and helped bring the cause to a national stage. Today, Hyundai and Genesis dealers across the U.S. contribute to the initiative, alongside Hyundai Motor America, forming a joint effort that has significantly expanded the reach and resources dedicated to fighting childhood cancer.
From the Showroom to the Stadium
More than 800 dealers are now part of the Hope On Wheels network. But their role goes beyond funding. Reilly emphasizes the importance of storytelling—educating customers who visit dealerships and spreading awareness through local and regional events. Whether it’s a handprint-covered vehicle at an auto show or branded presence at a tennis tournament, the initiative brings purpose into every customer touchpoint.
Handprints With Meaning
One of the most powerful visual elements of Hope On Wheels is the collection of handprints—left by children who are battling or surviving cancer. These symbols spark conversations and connect customers to the cause. When someone buys a vehicle from a participating dealership, they’re supporting pediatric cancer research in a meaningful, visible way.
A Global Expansion, A Shared Mission
Now in its 27th year, Hope On Wheels is going beyond U.S. borders. In 2024, the initiative expanded into Canada and Mexico, officially covering all of North America. Reilly highlights that pediatric cancer is a global issue, and Hyundai is committed to connecting researchers across borders through a shared network, accelerating progress toward a cure.
For more conversations with industry leaders, explore the full Talks with Teads series.